EARLY IMPACT OF MMAT-3 POLICY ON LIVER TRANSPLANT OUTCOMES FOR HEPATOCELLULAR CARCINOMA

被引：0
|
作者：
Shaikh, Anjiya T.
Rich, Nicole E.
Benhammou, Jihane N.
Goss, John A.
Kim, Donghee
Ahmed, Aijaz
Rana, Abbas
Lee, Tzu-Hao
Kanwal, Fasiha
Cholankeril, George T.
机构：
来源：
GASTROENTEROLOGY | 2022年 / 162卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
435
引用
收藏
页码：S1127 / S1127
页数：1
相关论文
共 50 条
  • [1] Early Impact of MMaT-3 Policy on Liver Transplant Waitlist Outcomes for Hepatocellular Carcinoma
    Shaikh, Anjiya
    Goli, Karthik
    Rich, Nicole E.
    Benhammou, Jihane N.
    Khaderi, Saira
    Hernaez, Ruben
    Agopian, Vatche G.
    Vierling, John M.
    Kim, Donghee
    Ahmed, Aijaz
    Goss, John A.
    Rana, Abbas
    Kanwal, Fasiha
    Cholankeril, George
    TRANSPLANTATION DIRECT, 2022, 8 (05): : E1313
  • [2] Chasing equity: The evolving effects of MMaT-3 policy on outcomes of liver transplantation for hepatocellular carcinoma
    Choi, Anthony J.
    Brown Jr, Robert S.
    LIVER TRANSPLANTATION, 2023, 29 (10) : 1027 - 1028
  • [3] Racial-Ethnic Disparities in Liver Transplant Waitlist Outcomes in Patients with Hepatocellular Carcinoma Before and After the MMaT-3 Policy
    Mazur, Rafal
    Cron, David
    Goldberg, David
    Yeh, Heidi
    Dageforde, Leigh Anne
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (01) : S56 - S57
  • [4] Survival following liver transplantation for hepatocellular carcinoma after implementation of MMaT-3 policy
    Shaikh, Anjiya
    Lee, Tzu-Hao
    Rich, Nicole E.
    Benhammou, Jihane N.
    Lymberopoulos, Peter
    Agopian, Vatche G.
    Kim, Donghee
    Ahmed, Aijaz
    Hernaez, Ruben
    Berg, Carl L.
    Goss, John
    Rana, Abbas
    Kanwal, Fasiha
    Cholankeril, George
    LIVER TRANSPLANTATION, 2023, 29 (10) : 1138 - 1142
  • [5] EFFECT OF THE MMAT-3 POLICY ON POST-TRANSPLANT OUTCOMES
    Shaikh, Anjiya
    Lymberopoulos, Peter
    Rich, Nicole E.
    Benhammou, Jihane N.
    Goss, John A.
    Rana, Abbas
    Lee, Tzu-Hao
    Kanwal, Fasiha
    HEPATOLOGY, 2022, 76 : S7 - S7
  • [6] MMaT-3 Policy Implementation is Associated with Decreased Access to Transplant and Increased Use of Higher Risk Allografts for Hepatocellular Carcinoma Patients
    Przybyszewski, E. M.
    Mitten, E. K.
    Yagos, S.
    Irwin, L.
    Bhan, I.
    Bethea, E. D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S575 - S575
  • [7] Impact of MMaT Policy on Transplant for Hepatocellular Carcinoma at a Single Center.
    Kodali, S.
    Victor, D. W.
    Corkrean, J.
    Shetty, A.
    Mobley, C.
    Hobeika, M.
    McMillan, R.
    Graviss, E. A.
    Nguyen, D. T.
    McFadden, R.
    Ankoma-Sey, V.
    Egwim, C.
    Galati, J.
    Saharia, A.
    Ghobrial, R. M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 830 - 830
  • [8] Surging Liver Transplant Rates for Alcohol-Associated Liver Disease May Exacerbate Waitlist Death of Patients with Hepatocellular Carcinoma in MMAT-3 Era.
    Yuan, L.
    Dodge, J. L.
    Zhou, K.
    Terrault, N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 828 - 829
  • [9] Policy corner: What's my MELD score? MMAT-3
    Rosenstengle, Craig
    Trotter, James
    Mehta, Shivang
    LIVER TRANSPLANTATION, 2024, 30 (06) : 659 - 660
  • [10] The Impact of a Liver Transplant Program on the Outcomes of Hepatocellular Carcinoma
    Endo, Yutaka
    Sasaki, Kazunari
    Moazzam, Zorays
    Woldesenbet, Selamawit
    Yang, Jason
    Lima, Henrique Araujo
    Alaimo, Laura
    Munir, Muhammad Musaab
    Shaikh, Chanza F.
    Schenk, Austin
    Kitago, Minoru
    Pawlik, Timothy M.
    ANNALS OF SURGERY, 2023, 278 (02) : 230 - 238
12345